Valerie Fleishman provides the strategic and operational direction for NEHI. As Executive Director, she oversees the institute’s policy research, programs, operations, fundraising and communications. Under her leadership, NEHI's programs seek to improve chronic illness care, promote disease prevention and wellness, and speed the adoption of valuable innovations across the health care system. She has authored numerous reports, articles and briefs on a wide range of health policy issues.
Ms. Fleishman joined NEHI at its founding in 2002. She has over fifteen years’ experience in health care, health policy, technology and innovation. Prior to joining NEHI, Ms. Fleishman was a director in Health and Wellness at Scient Corporation, where she led strategic consulting engagements with leading biotechnology, medical device and pharmaceutical clients in areas such as telemedicine, disease management, health information technology, clinical trials, and sales and marketing strategies.
Previously, Ms. Fleishman was a manager in Arthur D. Little's Global Strategy Practice. She also worked in product management and brand marketing at Johnson & Johnson's McNeil Consumer Products.
Ms. Fleishman received her bachelor of arts, cum laude, from Harvard University and her master of business administration from the Harvard Business School. In 2008, she was honored as one of Boston’s "40 under 40" by the Boston Business Journal.
Jonathan J. Fleming is President and Treasurer of NEHI. Since 1999, Mr. Fleming has been the Managing Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science investments, based in Boston, MA. Mr. Fleming has been in the investment business for more than 29 years, starting and financing growth companies in the United States, Europe, Israel and Asia. Prior to joining Oxford Bioscience Partners in 1996, he was a Founding General Partner of MVP Ventures in Boston, MA. He began his investment career with TVM Techno Venture Management in Munich, Germany. Mr. Fleming also co-founded Medica Venture Partners, a venture capital investment firm specializing in early stage health care and biotechnology companies in Israel, and the Korea Seoul Life Science Fund, based in Seoul, Korea. Mr. Fleming is a director of Xencor (NASDAQ: XNCR) and several private early stage life science companies. He is also a director of Leerink Partners, a Boston based investment bank specializing in health care companies. In addition, Mr. Fleming has been a Senior Lecturer at the MIT Sloan School of Management since 2003, where he co-teaches a class on business strategy for life science managers. He is an advisor to the SBIR program of the National Cancer Institute. Mr. Fleming holds a Master's degree in Public Administration from Princeton University’s Woodrow Wilson School of Public and International Affairs, and a Bachelor's degree in Political Science from the University of California, Berkeley.